HHS plans to create two new FDA deputy commissioner roles: one for technology/AI and another for drugs, aiming to increase influence over the agency. Following CNBC's report, AI healthcare stocks like Twist Bioscience and Tempus AI rose. Jared Seehafer is a leading contender for the tech role, while both appointees will report to nominee Heidi Overton. No formal announcements have been made yet.